APA (7th ed.) Citation

MA, W., S, L., R, M., C, C., SW, Y., & MVS, V. (2025). Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions. Drug metabolism and disposition: the biological fate of chemicals, 53(4), 100056. https://doi.org/10.1016/j.dmd.2025.100056

Chicago Style (17th ed.) Citation

MA, West, Lazzaro S, Morrow R, Costales C, Yee SW, and Varma MVS. "Significance of Gut Breast Cancer Resistance Protein Versus Organic Anion Transporting Polypeptide 2B1 Inhibition on Rosuvastatin Clinical Drug-drug Interactions." Drug Metabolism and Disposition: The Biological Fate of Chemicals 53, no. 4 (2025): 100056. https://doi.org/10.1016/j.dmd.2025.100056.

MLA (9th ed.) Citation

MA, West, et al. "Significance of Gut Breast Cancer Resistance Protein Versus Organic Anion Transporting Polypeptide 2B1 Inhibition on Rosuvastatin Clinical Drug-drug Interactions." Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 53, no. 4, 2025, p. 100056, https://doi.org/10.1016/j.dmd.2025.100056.